Netherlands Proteomics Centre
► Login
Biomarker discovery for head and neck cancer

Biomarker discovery for head and neck cancer

January, 2010

Annually, some 2,500 people in the Netherlands are diagnosed with head and neck cancer. In 20-40% of patients, the tumour returns after surgery. Up to now, it was impossible to predict among which patients this could occur.

In her PhD study, Netherlands Proteomics Centre researcher Tieneke Schaaij-Visser used proteomics techniques to compare hundreds of proteins of normal and (pre)cancer tissues of patients. She has managed to identify a number of proteins (biomarkers), with which one can effectively predict which treated patients have a significant risk of
a recurring tumour.

High-quality proteomics research

Contact      Telephone   +31 30 253 45 64      |      Fax   +31 30 253 69 18      |      Email      |      Privacy settings